Market closedADR

Novartis/$NVS

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Novartis

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Ticker

$NVS

Trading on

NYSE

Industry

Pharmaceuticals

Headquarters

Basel, Switzerland

Employees

76,057

Novartis Metrics

BasicAdvanced
$206B
Market cap
12.04
P/E ratio
$8.58
EPS
0.51
Beta
$2.43
Dividend rate
2.35%
Dividend yield
$206B
0.51
$120.06
$92.35
1.2M
$2.43
1.111
0.782
58.346
74.029
43.31%
19.33%
10.59%
28.79%
12.039
4.208
4.2
-19.13
16.741
2.35%
2.35%
8.92%
130.53%
-1.58%
25.61%
4.94%

What the Analysts think about Novartis

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Novartis stock.

Novartis Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Novartis Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $NVS

$

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Novartis stock?

Novartis (NVS) has a market cap of $206B as of November 21, 2024.

What is the P/E ratio for Novartis stock?

The price to earnings (P/E) ratio for Novartis (NVS) stock is 12.04 as of November 21, 2024.

Does Novartis stock pay dividends?

Yes, the Novartis (NVS) stock pays dividends to shareholders. As of November 21, 2024, the dividend rate is $2.4307 and the yield is 2.35%. Novartis has a payout ratio of 43.31% on a trailing twelve-month basis.

When is the next Novartis dividend payment date?

The next Novartis (NVS) dividend payment date is unconfirmed.

What is the beta indicator for Novartis?

Novartis (NVS) has a beta rating of 0.51. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.